Another great post by JFM to a

New Post Public Reply Private Reply Replies (1) Message Board
Rip Van 03
658
Another great post by JFM to a basher:

XXXXXXXXXX...

Your attempt to discredit another post, which noted:

Brilacidin via RBL's “... has proven to be over 90 percent effective in destroying Covid-19 AND its variants in lab results”

by asserting:

"Incorporating such obvious “inaccuracies “ into your communications will diminish their impact considerably"

...is like spitting in the wind!

I AGREE...that INCORPORATING SUCH OBVIOUS INACCURACIES...DIMINISH COMMUNICATIONS IMPACT...AS WITH YOURS!!!

But...by also posting:

"Once again your statement that brilacidin has been shown to be effective against variant COVID-19 strains is flat out false."


...is in itself...FLAT OUT FALSE.

Tyrus603...was obviously using "effective" as meaning the REDUCTION IN COVID-19 VIRAL LOAD, using human tissue, as much as 97% as reported by RBL after extensive testing ... ...

WHICH IS ABSOLUTELY CORRECT...

...unless of course you are implying that we are to believe that what Rutgers Univ. and GMU Univ. reported...i.e. the REDUCTIONS IN VIRAL LOADS up to 97% in their labs...was some kind of co-conspiracy by the Labs...with Leo/CEO in publishing the PR below...

...and that they together fooled the FDA accepting those (your) "alleged inaccuracies" resulting in the...

FDA GRANTING ..."INVESTIGATIONAL NEW DRUG" approval AND "FAST TRACT DESIGNATION"...just last month!

YES...“inaccuracies “ into your communications will diminish their impact considerably"!!!

Read PRESS RELEASE SUMMARIZING ... INDEPENDENT GOV SPONSORED lab results for Brilacidin:

http://www.ipharminc.com/press-release/2020/6...-cell-line

· "Brilacidin is a unique 3-in-1 antiviral, anti-inflammatory, antimicrobial COVID-19 drug candidate..."

"Brilacidin exhibited a statistically significant (p<0.0001) and potent inhibitory effect on SARS-CoV-2, the novel coronavirus responsible for COVID-19, in a human lung epithelial cell line—reducing viral load by 95 percent and by 97 percent, compared to control, at two therapeutic concentrations tested. Based on a CC50 value—the concentration of drug at which 50 percent of cells maintain viability—Brilacidin was also shown to be non-cytotoxic in the lung cell line.

The new lung cell line data reinforce previous testing conducted at the RBL, in VERO cells, where Brilacidin showed a similar robust inhibition, of 75 percent, against SARS-CoV-2 compared to control. Brilacidin has also been shown, in testing at the RBL, to be non-cytotoxic in VERO cells."


“Brilacidin has now demonstrated potent inhibition of SARS-CoV-2 in human lung and kidney cell lines, and in VERO cells, in laboratory testing conducted by independent academic researchers at two institutions, both of whom plan to submit their findings for peer-review publication,” said Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals. “The antiviral data we are compiling provides compelling proof of Brilacidin’s impressive ability to inhibit the novel coronavirus, toward initiating a clinical study of Brilacidin for COVID-19.”

PS. Those clinical trials...are EXPECTED TO BE INITIATED THIS WEEK...to prove out the lab results in humans!

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TCL Drives Fan Experience at FIBA Women's World Cup

Updated Category News Views 5

TCL's Slam Dunk on the Global Stage The FIBA Women's Basketball World Cup 2026 in Berlin is set to showcase some incredible talent, and TCL is right in the thick of it. As a FIBA Global Partner, they're spearheading a new wave of fan interactions with their TCLforHer initiative, focusing on tech-enabled fan experiences that go beyond just watching the game. This isn't...

Continue Reading
viaim's AI Earbuds Snag IFA Awards, Launch On Indiegogo

Updated Category News Views 1

When the tech cosmos hands you two hefty IFA Innovation Awards, you know you’re onto something. viaim’s Rise wasn't just about slick marketing—it brought home the 'Best in Audio' and 'Best in Design' titles from IFA 2026, proving these earbuds are more than just another gadget. Key Innovations Behind the Accolades IFA is no small affair—it's a major tech trade...

Continue Reading
SIAL West Asia Ignites Global F&B Trade at Guangzhou

Updated Category News Views 3

A Convergence of Global Taste You could feel the buzz in the air as the 2026 SIAL West Asia International Food Exhibition kicked off at the Guangzhou Poly World Trade Center Expo. Throw over 1,500 exhibitors from the far corners of the globe into a sprawling 60,000-square-meter trade floor, and you've got yourself a melting pot of flavors and cultures revolving around a...

Continue Reading
PrimeBOT Shines at IFA 2026 with Innovative Awards

Updated Category News Views 6

A New Chapter in Home Robotics In today's tech-centric world, newcomers often confuse flash with substance. But every now and then, you catch a glimpse of something that might just change how the world spins. At this year's IFA 2026, PrimeBOT didn't just dip its toes into the limelight—it cannonballed right in, drumming up some serious buzz with its PrimeBOT T1 and...

Continue Reading
UGREEN's AI Hub: Privacy-First Tech for Smart Homes

Updated Category News Views 1

UGREEN's Big AI Leap In the bustling scene of home tech evolution, UGREEN's throwing its hat in the ring with its latest offerings. They've just rolled out the UGREEN HomeAgent series, aiming to redefine what we think of when it comes to smart living. UGREEN, usually known for its tech gadgets, is diving headfirst into the smart home pool. These local AI hubs blend tech...

Continue Reading
Consumer365 Lauds Happy Head's Custom Hair Treatments

Updated Category News Views 6

Revolutionizing Hair Loss Treatment The world of hair growth solutions is transforming right before our eyes. Thanks to the folks over at Happy Head and their customizable, dermatologist-prescribed treatments, the days of one-size-fits-all are ending. Consumer365 recently took a dive into Happy Head's model, giving their nod of approval to its personalized approach....

Continue Reading
PureHealth Research Spotlights Simpler Supplement Trends

Updated Category News Views 2

What's Steering the Supplement Ship? Well, if you're paying any attention to the supplement space, you might've noticed something curious: folks are ditching complicated concoctions for good old fashioned simplicity. PureHealth Research, out of Manassas, is throwing the limelight on this trend, where people are handing in their multi-ingredient cocktail for a single...

Continue Reading
China Hour Expands Chinese Media Footprint in Africa

Updated Category News Views 2

An Ambitious Cross-Continental Media Play The airwaves are getting a new twist. This time, it's a blend of cultures, as China Hour makes an entrance in South Africa. That's right, folks—Jiangsu Broadcasting Corporation (JSBC) has set up camp alongside the South African Broadcasting Corporation (SABC), pushing a big media wave across the continent. If you've been...

Continue Reading
Why Buyers Are Flocking to Whidbey Island Homes

Updated Category News Views 1

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

Continue Reading
Carles Puyol Joins Midea at IFA 2026, Celebrating Unity

Updated Category News Views 3

Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...

Continue Reading

Top 5 Most Recently Viewed Articles

TSMC Breaks Ground with 4-Nanometer Chips Production in the U.S.

Updated Category News Views 354

TSMC Launches 4-Nanometer Chip Production in the U.S. TSMC, or Taiwan Semiconductor Manufacturing Company, has achieved a remarkable milestone by beginning the production of advanced 4-nanometer chips in Arizona. This marks a significant step in the Biden administration's efforts to strengthen domestic semiconductor manufacturing. Significant Investment and Expansion...

Continue Reading
Rezolve Ai Completes Major Loan Conversions for Financial Growth

Updated Category News Views 155

Rezolve Ai Takes Significant Steps Towards Financial Robustness Rezolve Ai (NASDAQ: RZLV), a prominent player in the realm of AI-driven retail solutions, has recently made headlines by converting variable rate convertible loans amounting to approximately $59 million. This strategic move, completed before the year's end, not only strengthens the company's financial...

Continue Reading
Filecoin Network Supports Cultural Institutions' Digital Archives

Updated Category News Views 286

Filecoin Network Enhances Cultural Preservation Efforts In the digital age, the need for preserving significant cultural artifacts is more crucial than ever. The Filecoin Foundation is taking significant strides by partnering with esteemed organizations like the Smithsonian Institution, Flickr Foundation, Internet Archive, and MIT Open Learning. Together, they are adding...

Continue Reading
Mowi's Impressive Operational Performance in Q1 2025

Updated Category News Views 396

Outstanding Operational Results from Mowi Mowi has reported remarkable financial outcomes for the first quarter of the year, showcasing a revenue of 1.36 billion euros (15.8 billion Norwegian kroner) alongside an operational EBIT of 214 million euros (2.5 billion Norwegian kroner). This performance marks a significant increase compared to the previous year’s results,...

Continue Reading
DocuSign Shares Surge After Strong Earnings Report

Updated Category News Views 185

DocuSign Reports Strong Financial Performance DocuSign, Inc. (NASDAQ: DOCU) showed remarkable progress as its stock experienced a significant increase following the release of its fourth-quarter earnings report for the 2025 fiscal year. Investors reacted positively to the unveiling of financial results that exceeded market expectations, demonstrating the company’s...

Continue Reading